1Clinical value of circ-BCAS3 in plasmal exosomes of patients with pancreatic cancerTAI Ping, WU JianfengARTICLES961-9662Erastin inhibits proliferation of ovarian cancer cells by regulating GSK-3β/NRF2 pathwayZHANG Sunyu, ZHU YanARTICLES967-9723Expression and clinical significance of PD-L1 and FOXP3 in papillary thyroid carcinomaCHEN Song, ZHAO Daiwei, LUO Xue, GAO QingjunARTICLES973-9794Clinicopathological analysis of nerve invasion and tumor budding in pancreatic ductal adenocarcinomaNIAN Rui, LI Wanjun, LI Weihua, CHENG Jing, ZHANG GuanjunARTICLES980-9845Expression and prognostic value of autophagy related proteins Beclin-1 and p62 in diffuse large B-cell lymphomaMA Changhong, ZHANG Jingnan, QIAO Shukai, XING Lina, TIAN Tian, GUO XiaonanARTICLES985-9906A single-center study on combining mismatch repair protein immunohistochemistry and gene next-generation sequencing for Lynch syndrome screening in colorectal cancerHUANG Wei, GU Ruidong, ZHANG Yu, BIAN Jin, QIAN Xiaoping, WANG LinARTICLES991-9967Clinical observation of PD-1 inhibitors on advanced HER-2 negative gastric cancerNING Jie, JIAO Yang, PENG Wanren, DU Yingying, MA Tai, GU KangshengARTICLES997-10038Prognostic value of spleen SUVMAX in pretreatment 18F-FDG PET/CT imaging of angioimmunoblastic T-cell lymphomaGONG Huanyu, DING Chongyang, HU Yao, TANG LijunARTICLES1004-10109Clinical observation and primany treatment choice for patients with low-risk gestational trophoblastic neoplasmZHU Ye, LI Juan, LEI Yue, SU Yiping, QI DanCLINICAL PRACTICE1011-101510Analysis of clinicopathological features of nephrogenic adenomainthe urinaryZHANG Tao, FENG Lijuan, ZHANG Kaineng, FENG Wenbo, YIN Sifan, KE ChangxingCLINICAL PRACTICE1016-101911Pathophysiology and pathogenesis of cancer cachexia:the direction of cachexia treatmentHE Guoping, QIU Minghan, ZHAO Xuanzhu, MEI Hanwei, QI Ruili, WANG HuaqingREVIEWS AND LECTURES1028-103512Exploration of adjuvant and neoadjuvant treatment options for triple-negative breast cancerSHAN Zhen, LIN YingREVIEWS AND LECTURES1036-104513Choice of taxanes in breast cancer——from pharmaceutical mechanism to clinical trialsLI Su, XU BingheREVIEWS AND LECTURES1046-1051 